Mostrar el registro sencillo del ítem

dc.contributor.authorGil-Miravet, Isis
dc.contributor.authorFuertes-Saiz, Alejandro
dc.contributor.authorBenito, Ana
dc.contributor.authorAlmodóvar, Isabel
dc.contributor.authorOchoa, Enrique
dc.contributor.authorHaro Cortés, Gonzalo
dc.date.accessioned2021-04-13T07:59:42Z
dc.date.available2021-04-13T07:59:42Z
dc.date.issued2021-02
dc.identifier.citationGil-Miravet, I.; Fuertes-Saiz, A.; Benito, A.; Almodóvar, I.; Ochoa, E.; Haro, G. Prepulse Inhibition in Cocaine Addiction and Dual Pathologies. Brain Sci. 2021, 11, 269. https://doi.org/10.3390/brainsci11020269ca_CA
dc.identifier.issnhttps://doi.org/10.3390/brainsci11020269
dc.identifier.urihttp://hdl.handle.net/10234/192805
dc.description.abstractCocaine addiction is frequently associated with different psychiatric disorders, especially schizophrenia and antisocial personality disorder. A small number of studies have used prepulse inhibition (PPI) as a discriminating factor between these disorders. This work evaluated PPI and the phenotype of patients with cocaine-related disorder (CRD) who presented a dual diagnosis of schizophrenia or antisocial personality disorder. A total of 74 men aged 18–60 years were recruited for this research. The sample was divided into four groups: CRD (n = 14), CRD and schizophrenia (n = 21), CRD and antisocial personality disorder (n = 16), and a control group (n = 23). We evaluated the PPI and other possible vulnerability factors in these patients by using different assessment scales. PPI was higher in the CRD group at 30 ms (F(3, 64) = 2.972, p = 0.038). Three discriminant functions were obtained which allowed us to use the overall Hare Psychopathy Checklist Revised score, reward sensitivity, and PPI at 30 ms to predict inclusion of these patients in the different groups with a success rate of 79.7% (42.9% for CRD, 76.2% for CRD and schizophrenia, 100% for CRD and antisocial personality disorder, and 91.3% in the control group). Despite the differences we observed in PPI, this factor is of little use for discriminating between the different diagnostic groups and it acts more as a non-specific endophenotype in certain mental disorders, such as in patients with a dual diagnosis.ca_CA
dc.format.extent14 p.ca_CA
dc.format.mimetypeapplication/pdfca_CA
dc.language.isoengca_CA
dc.publisherMDPIca_CA
dc.relationTeaching + Research 2016 and Teaching + Research 2017ca_CA
dc.relationRedes Temáticas de Investigación Cooperativa en Salud (RETICS), Red de Trastornos Adictivos, Complications of stimulant disorderca_CA
dc.relation.isPartOfBrain Sciences, 2021, vol. 11, no 2ca_CA
dc.rightsAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-sa/4.0/*
dc.subjectdual diagnosisca_CA
dc.subjectschizophreniaca_CA
dc.subjectantisocial personality disorderca_CA
dc.subjectcocaine-related disorderca_CA
dc.subjectpsychopathyca_CA
dc.subjectprepulse inhibitionca_CA
dc.titlePrepulse Inhibition in Cocaine Addiction and Dual Pathologiesca_CA
dc.typeinfo:eu-repo/semantics/articleca_CA
dc.identifier.doihttps://doi.org/10.3390/brainsci11020269
dc.rights.accessRightsinfo:eu-repo/semantics/openAccessca_CA
dc.relation.publisherVersionhttps://www.mdpi.com/2076-3425/11/2/269ca_CA
dc.type.versioninfo:eu-repo/semantics/publishedVersionca_CA
project.funder.nameUniversidad CEU Cardenal Herreraca_CA
project.funder.nameMinisterio de Economía, Industria y Competitividadca_CA
project.funder.nameInstituto de Salud Carlos IIIca_CA
project.funder.nameFondo Europeo de Desarrollo Regional (FEDER)ca_CA
project.funder.nameFundación del Hospital Provincial de Castellónca_CA
oaire.awardNumberRD16/0017/0024ca_CA
oaire.awardNumberCAF-20-026ca_CA
oaire.awardNumberCAF-20-027ca_CA


Ficheros en el ítem

Thumbnail
Thumbnail
Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como: Atribución 4.0 Internacional